Afamelanotide assists DNA repair response following UV radiation 2024 Announcements . Clinical . News 05.07.2024
SCENESSE® European Orphan Drug Designation for Variegate Porphyria 2024 Announcements . Clinical . News 24.06.2024
Technical note: Afamelanotide as MC1R-targeted therapy in Parkinson’s [PD] 2024 Announcements . Clinical . News 18.06.2024
CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria 2024 Announcements . Clinical . News 03.06.2024
SCENESSE® efficacy in vitiligo: new case presented at AAD 2024 Announcements . Clinical . News . Regulatory 11.03.2024
SCENESSE® provides photoprotection, improves QoL in variegate porphyria 2024 Announcements . Clinical . News . Regulatory 04.03.2024
CLINUVEL PHARMACEUTICALS LTD Annual General Meeting – Notice of Meeting & Explanatory Memorandum 2023 2023 Announcements . Clinical . News 29.09.2023